Patient Experience of Treatment with Tirzepatide for Weight Management: Exit Interviews from SURMOUNT-4
Study findings showed that beyond the direct pharmacological effects of treatment with tirzepatide, participants reported a wide range of perceived improvements across several aspects of their lives. Participants also reported a few negative experiences, including side effects. It is possible that the participants who had a more positive experience were more inclined to participate in the exit interviews. This study highlights the value of exit interviews, which can provide more learning about patient experiences during a clinical trial.
Authors
- Chisom Kanu (ORCID: https://orcid.org/0000-0002-2621-8652)
- Donna Mojdami
- Helen Kitchen (ORCID: https://orcid.org/0000-0001-5519-0794)
- Jiat Ling Poon (ORCID: https://orcid.org/0000-0001-7038-2102)
- Nadia Ahmad (ORCID: https://orcid.org/0000-0003-3607-0740)
- Chloe Carmichael (ORCID: https://orcid.org/0000-0002-2278-2176)
- Irina Jouravskaya
- Danielle Burns
- Elizabeth Collins (ORCID: https://orcid.org/0000-0002-2117-6967)
- Madhumita Murphy
Institutions
- Eli Lilly (United States) (US)
Publication Details
- Journal
- Patient
- Published
- 2025-02-22
- DOI
- https://doi.org/10.1007/s40271-025-00730-0
- Citations
- 1
- Primary Topic
- Obesity and Health Practices
- Type
- article
- Field-Weighted Citation Impact
- 2.02
Funders
- Eli Lilly and Company